Sophia Danhof

2.6k total citations
42 papers, 1.0k citations indexed

About

Sophia Danhof is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Sophia Danhof has authored 42 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 21 papers in Molecular Biology and 21 papers in Hematology. Recurrent topics in Sophia Danhof's work include CAR-T cell therapy research (24 papers), Multiple Myeloma Research and Treatments (21 papers) and Protein Degradation and Inhibitors (9 papers). Sophia Danhof is often cited by papers focused on CAR-T cell therapy research (24 papers), Multiple Myeloma Research and Treatments (21 papers) and Protein Degradation and Inhibitors (9 papers). Sophia Danhof collaborates with scholars based in Germany, United States and Spain. Sophia Danhof's co-authors include Hermann Einsele, Michael Hudecek, Martin Schreder, Sabrina Prommersberger, Tea Gogishvili, Leo Rasche, Julian Rydzek, Christian Brede, Stefan Knop and Markus Sauer and has published in prestigious journals such as Nature Communications, Blood and Molecular Microbiology.

In The Last Decade

Sophia Danhof

39 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sophia Danhof Germany 16 706 519 412 270 146 42 1.0k
Mehmet H. Kocoglu United States 15 605 0.9× 392 0.8× 455 1.1× 243 0.9× 76 0.5× 60 996
Anthony F. Daniyan United States 12 784 1.1× 326 0.6× 139 0.3× 363 1.3× 241 1.7× 24 1.0k
Jean A. Yared United States 15 463 0.7× 205 0.4× 173 0.4× 206 0.8× 68 0.5× 66 838
Maya C. André Germany 17 355 0.5× 275 0.5× 211 0.5× 441 1.6× 76 0.5× 30 925
Leonardo Mirandola United States 20 439 0.6× 606 1.2× 188 0.5× 512 1.9× 31 0.2× 58 1.1k
Kelly M. Ramsbottom Australia 16 462 0.7× 414 0.8× 146 0.4× 654 2.4× 76 0.5× 22 1.0k
Kathryn M. Cappell United States 11 1.0k 1.5× 587 1.1× 65 0.2× 420 1.6× 249 1.7× 16 1.4k
Yuriko Fujita Japan 7 1.0k 1.4× 465 0.9× 110 0.3× 418 1.5× 277 1.9× 19 1.3k
Xing-Mei Cao China 11 218 0.3× 191 0.4× 179 0.4× 188 0.7× 37 0.3× 33 509
Semjon Willier Germany 11 422 0.6× 343 0.7× 58 0.1× 175 0.6× 94 0.6× 21 707

Countries citing papers authored by Sophia Danhof

Since Specialization
Citations

This map shows the geographic impact of Sophia Danhof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophia Danhof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophia Danhof more than expected).

Fields of papers citing papers by Sophia Danhof

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sophia Danhof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophia Danhof. The network helps show where Sophia Danhof may publish in the future.

Co-authorship network of co-authors of Sophia Danhof

This figure shows the co-authorship network connecting the top 25 collaborators of Sophia Danhof. A scholar is included among the top collaborators of Sophia Danhof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sophia Danhof. Sophia Danhof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weber, Justus, Charis Kalogirou, Jörg Lehmann, et al.. (2025). ROR2-specific CAR T cells are effective against hematologic and solid tumors and well tolerated in mice. Cell Reports Medicine. 6(10). 102400–102400.
2.
Egri, Péter, Carmen Sanges, Sophia Danhof, et al.. (2024). Reinforcement Learning Based Resource Management for CAR T-Cell Therapies. Procedia CIRP. 125. 154–159. 1 indexed citations
3.
4.
Luu, Maik, et al.. (2023). CAR-T-Zell-basierte Immuntherapien in der Hämatoonkologie. PubMed Central. 29(2). 160–172. 1 indexed citations
5.
García‐Guerrero, Estefanía, Luis Gerardo Rodríguez‐Lobato, Sophia Danhof, et al.. (2022). All-trans retinoic acid works synergistically with the γ-secretase inhibitor crenigacestat to augment BCMA on multiple myeloma and the efficacy of BCMA-CAR T cells. Haematologica. 108(2). 568–580. 24 indexed citations
6.
7.
Prommersberger, Sabrina, Michael Reiser, Julia Beckmann, et al.. (2021). CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma. Gene Therapy. 28(9). 560–571. 113 indexed citations
8.
Zhou, Xiang, Hermann Einsele, & Sophia Danhof. (2021). CAR-T-Zell-Therapie beim multiplen Myelom. Der Internist. 62(6). 605–610. 3 indexed citations
9.
Rodríguez‐Lobato, Luis Gerardo, et al.. (2020). CAR T-Cells in Multiple Myeloma: State of the Art and Future Directions. Frontiers in Oncology. 10. 1243–1243. 63 indexed citations
10.
García‐Guerrero, Estefanía, Ralph Götz, Sören Doose, et al.. (2020). Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab. Leukemia. 35(1). 201–214. 53 indexed citations
11.
Danhof, Sophia, Martin Schreder, Antonio Giovanni Solimando, et al.. (2019). Exploration of Artificial Intelligence Use with ARIES in Multiple Myeloma Research. Journal of Clinical Medicine. 8(7). 999–999. 8 indexed citations
12.
Balen, Peter van, Lothar Germeroth, Lois Hageman, et al.. (2019). Generation and infusion of multi-antigen-specific T cells to prevent complications early after T-cell depleted allogeneic stem cell transplantation—a phase I/II study. Leukemia. 34(3). 831–844. 19 indexed citations
13.
Danhof, Sophia, Susanne Strifler, K. Martin Kortüm, et al.. (2018). Clinical and biological characteristics of myeloma patients influence response to elotuzumab combination therapy. Journal of Cancer Research and Clinical Oncology. 145(3). 561–571. 14 indexed citations
14.
Gogishvili, Tea, Sophia Danhof, Sabrina Prommersberger, et al.. (2017). SLAMF7-CAR T cells eliminate myeloma and confer selective fratricide of SLAMF7+ normal lymphocytes. Blood. 130(26). 2838–2847. 184 indexed citations
15.
Rasche, Leo, Christoph Röllig, Gernot Stuhler, et al.. (2016). Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Focus on Longitudinal Assessment of Donor Chimerism, Extramedullary Disease, and High-Risk Cytogenetic Features. Biology of Blood and Marrow Transplantation. 22(11). 1988–1996. 35 indexed citations
16.
García‐Guerrero, Estefanía, Tea Gogishvili, Sophia Danhof, et al.. (2016). Panobinostat Induces Upregulation of CD38 and Augments the Anti-Myeloma Efficacy of Daratumumab in Pre-Clinical Models. Blood. 128(22). 4481–4481. 2 indexed citations
17.
Danhof, Sophia, Martin Schreder, Leo Rasche, et al.. (2015). ‘Real‐life’ experience of preapproval carfilzomib‐based therapy in myeloma – analysis of cardiac toxicity and predisposing factors. European Journal Of Haematology. 97(1). 25–32. 62 indexed citations
18.
Strifler, Susanne, Inken Hilgendorf, Martina Kleber, et al.. (2015). The Contribution of a Third Autologous Stem Cell Transplant in the Era of Novel Agents: Favourable Overall Survival and Improvement of Exhausted Bone Marrow Function. Clinical Lymphoma Myeloma & Leukemia. 15. e287–e288. 1 indexed citations
19.
Danhof, Sophia, Martin Schreder, Susanne Strifler, Hermann Einsele, & Stefan Knop. (2015). Long-Term Disease Control by Pomalidomide-/Dexamethasone-Based Therapy in a Patient with Advanced Multiple Myeloma: A Case Report and Review of the Literature. Case Reports in Oncology. 8(1). 189–195. 8 indexed citations
20.
Danhof, Sophia, Martin Schreder, Leo Rasche, et al.. (2015). Efficacy and Safety of Pre-approval Carfilzomib-Based Therapy of Multiple Myeloma in Daily Practice – Experience from a German Academic Center. Clinical Lymphoma Myeloma & Leukemia. 15. e284–e284. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mehmet H. Kocoglu Breakdown of academic impact, for papers by Anthony F. Daniyan Breakdown of academic impact, for papers by Jean A. Yared Breakdown of academic impact, for papers by Maya C. André Breakdown of academic impact, for papers by Leonardo Mirandola Breakdown of academic impact, for papers by Kelly M. Ramsbottom Breakdown of academic impact, for papers by Kathryn M. Cappell Breakdown of academic impact, for papers by Yuriko Fujita Breakdown of academic impact, for papers by Xing-Mei Cao Breakdown of academic impact, for papers by Semjon Willier
Rankless by CCL
2026